http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2291882-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b872cadbec9f5cb3afc8cd23aef15f0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e991dd827c2a6887aee0d6188377dfe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08dd08af16fa6299fb9079031a81b438 |
| publicationDate | 2008-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2291882-T3 |
| titleOfInvention | DERIVATIVES OF 2- (6-AMINO-PIRIDIN-3-IL) -2-HYDROXYETHYLAMINE AS BETA 2 ADRENOCEPTORS AGONISTS. |
| abstract | A compound of the formula: in which the group (CH2) nC (= O) Q1 is in the meta or para position, R1 and R2 are independently selected from H and C1-C4 alkyl, n is 0, 1 or 2 and Q1 is a group selected from: and a group * -NR-Q2-A, where p is 1, 2 or 3, q is 1 or 2, Q2 is a direct bond or a C1-C4 alkylene optionally substituted with OH, R is H, C1-C4 alkyl or phenyl optionally substituted with OH and A is C3-C7 cycloalkyl, said cycloalkyl being optionally linked by one or more carbon atoms, preferably 1 or 2 carbon atoms, tetrahydropyranyl, piperidinyl, tetrahydrothiopyranyl, pyridyl or a group selected from: where R3, R4, R5, R6 and R7 are the same or different and each is independently selected from H, C1-C4 alkyl, OR9, SR9, halo, CF3, OCF3, (CH2) mCOOR9, SO2NR8R9, CONR8R9 , NR8R9, NHCOR8, SO2-(C1-C4) alkyl and phenyl optionally substituted with hydroxy or hydroxy (C1-C4) alkyl; where m is an integer selected from 0, 1 and 2 and R8 and R9 are the same or different and are independently selected from H or C1-C4 alkyl and the * represents the point of attachment to the carbonyl group; or, if appropriate, its pharmaceutically acceptable salts and / or isomers, tautomers, solvates or isotopic variations. |
| priorityDate | 2003-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 469.